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Abstract
Background: Transposable elements (TEs) are abundant genomic sequences that have been found
to contribute to genome evolution in unexpected ways. Here, we characterize the evolutionary
and functional characteristics of TE-derived human genome regulatory sequences uncovered by the
high throughput mapping of DNaseI-hypersensitive (HS) sites.
Conclusion: The results reported here support the notion that TEs provide a specific genome-
wide mechanism for generating functionally relevant gene regulatory divergence between
evolutionary lineages.
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Background
Transposable elements (TEs) are DNA sequences capable
of moving among chromosomal locations within the
genome. TEs are copious genomic entities; at least half of
the human genome sequence is derived from TE inser-
tions [1,2]. While TEs were once thought to be purely self-
ish parasites concerned only with their own proliferation
[3], there are now numerous examples of TE sequences
that have been domesticated [4] to play some role for the
host genomes in which they reside [5]. One way that TEs
can achieve such a mutualistic status is through the dona-
tion of regulatory sequences that help control the expres-
sion of nearby host genes. For instance, recent genome-
wide studies have shown that TEs can be found in gene-
specific regulatory regions such as proximal promoters
and untranslated regions as well as regulatory sequences
that exert more global effects like scaffold/matrix attach-
ment regions and locus control regions [6,7]. LINE ele-
ments, in particular, have been demonstrated to have
genome-wide effects in lowering expression when
inserted within transcribed regions [8]. Comparative
sequence analyses have shown that many sequences from
two particular human TE families have evolved under
purifying selection, strongly suggesting a functional role
related to gene regulation [9]. More specifically, numer-
ous experimentally characterized cis-regulatory binding
sequences have been shown to be derived from TE inser-
tions [6,10], and a number of anecdotal cases of gene reg-
ulatory phenotypes governed by TE sequences have been
confirmed [11,12]. At the same time, TEs are known to be
among the least evolutionarily conserved elements in the
human genome [1]. Indeed, TE activity and insertions
often lead to the most substantial evolutionary differences
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between mammalian genome sequences [13,14]. Taken
together with their ability to donate regulatory sequences,
the lineage-specific nature of TEs suggests that they may
provide a specific mechanism for driving the regulatory
divergence between evolutionary lineages [10].
There are numerous experimental and computational
efforts underway aimed at characterizing the non-coding
portion of mammalian genomes [15]. Much of this work
is focused on elucidating the location and nature of regu-
latory sequences that control the expression of nearby
genes. An example of this kind of work is the large scale
attempt, spearheaded by the National Human Genome
Research Institute (NHGRI), to characterize a complete set
of human genome DNaseI-hypersensitive (HS) sites http:/
/research.nhgri.nih.gov/DNaseHS/May2005/. HS sites are
associated with gene regulatory regions, for upregulated
genes in particular, and mapping of HS sites is considered
to be among the most reliable experimental methods for
identifying regulatory sequences. HS sites have been
shown to be associated with a variety of regulatory regions
such as promoters, enhancers, suppressors, insulators,
and locus control regions [16].
Using recently developed high throughput experimental
methods, thousands of HS sites were cloned from human
CD4+ T cells [17,18] and sequenced using massively par-
allel signature sequencing [19]; results were confirmed
with real time PCR [20]. CD4+ T cells are a class of lym-
phocytes known as helper or effector T cells that serve to
activate and direct other immune cells. CD4+ T cells are
one of the primary targets of HIV infection, and depletion
of these cells leads to AIDS. Thus, the HS sites mapped to
the human genome by the NHGRI should correspond to
sequences that regulate gene expression related to CD4+ T
cell mediated immune response.
In this report, we have taken advantage of the genome-
wide mapping of HS sites in order to evaluate the contri-
bution of TEs to human gene regulatory sequences. The
extent of TE-derived HS sites in the human genome was
characterized, and the evolutionary conservation levels of
TE-derived versus non TE-derived HS sites were compared.
In addition, the expression and functional characteristics
of genes with TE-derived HS sites were evaluated along
with the evolutionary divergence of their sequences and
expression patterns. The results reported here indicate that
TEs have provided numerous functionally relevant HS
sites to the human genome, and these regulatory
sequences have played a role in driving functional diver-
gence along the human evolutionary lineage.
Results and discussion
Human genome DNaseI-hypersensitive sites
A total of 14,216 DNaseI-hypersensitive (HS) sites, cover-
ing ~4.2 megabases of DNA, are mapped to the hg17 ver-
sion (NCBI build 35) of the human genome sequence.
These sites consist of clusters of two or more experimen-
tally characterized HS sites that map within 500 bp of
each other. These HS sites were defined in CD4+ T cells
and are presumed to be functionally relevant with respect
to the regulation of gene expression in these cells. Given
the functional role played by HS sites, they are expected to
be anomalously conserved in terms of their levels of
sequence divergence. This is because the evolution of
functionally important sequences is constrained by puri-
fying selection (i.e. the removal of deleterious variants).
Indeed, this idea is the basis of the phylogenetic footprint-
ing approach that identifies putatively functional
genomic elements by virtue of their sequence conserva-
tion [21,22]. The expectation that HS sites should be evo-
lutionarily conserved was tested using the binary
characterization of human genome positions as conserved
or non-conserved based on analysis with the program
phastCons [23]. PhastCons employs a probabilistic hid-
den Markov model (HMM) that represents the levels of
DNA substitution at each site in the genome and how
these levels change among sites. The phastCons results
used here were based on a human query anchored multi-
ple sequence alignment (MSA) of 17 vertebrate genomes.
This MSA was assembled with the program multiz [24]
from whole genome pairwise alignments generated using
blastz [25]. The HMM used by phastCons employs a sin-
gle phylogenetic tree for all sites with the branch lengths
free to vary across sites. The HMM has two states – con-
served and non-conserved – based on the values of the
branch length scaling parameter estimated from the data.
Alignment sites (segments) are predicted as being con-
served if they are significantly more likely to have been
generated by the conserved state of the HMM.
All HS and non HS sites in hg17 were evaluated with
respect to their phastCons conservation designation. HS
sites in the human genome were found to be far more
conserved, on average, than sites non HS sites (Figure 1a):
~13% of HS sites are conserved compared to ~5% of non
HS sites. This comparison is conservative because the non
HS sites include numerous exons, most of which are con-
served. The figure of 5% conserved non HS sites is consist-
ent with previous estimates for the proportion of the
human genome evolving under purifying selection [23].
The greater than two-fold difference in conservation
between HS and non HS sites, together with the large
number of genome positions evaluated, yields a highly
statistically significant difference (χ2 = 5.2 × 106, P = 0; Fig-
ure 1b). These results are consistent with previous reports
that HS sites are i-enriched in human genome regions thatBiology Direct 2006, 1:20 http://www.biology-direct.com/content/1/1/20
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align with mouse genomic sequence [17] and ii-often
located near sequences conserved in multiple species [18].
However, it should be noted that the majority of HS sites
(~87%) analyzed here are not considered conserved by
the criteria employed by phastCons. Thus, many of these
sites, which are likely to be functionally important, might
not be detected using a naïve phylogenetic footprinting
approach.
Transposable element derived hypersensitive sites
The contribution of TEs to HS sites in the human genome
was evaluated by comparing the results of a RepeatMasker
[26] analysis of hg17 to the mapped locations of the
NHGRI HS sites. There are numerous TE-derived HS sites
in the human genome: 3,229 HS sites (~23%) include TE
sequence and 11% of all positions covered by HS sites
(454,564 bp) are derived from TEs. This substantial frac-
tion of HS sites derived from TEs is likely to be an under-
estimate since some TEs have diverged beyond
recognition and others may not be covered by the RepBase
library [27] employed by RepeatMasker. The relative fre-
quency distribution of TE classes found to donate HS sites
is largely similar to genomic distribution of TEs with a
slight over-representation of SINEs and according under-
representation of LINEs (Figure 2). This probably reflects
the fact that SINEs, such as Alus, are over-represented in
GC and gene rich regions of the genome, while LINEs tend
to be found in relatively gene poor AT-rich regions.
The evolutionary conservation of TE-derived HS sites was
compared to that of non TE-derived HS sites using the
same phastCons-based approach described previously.
HS site positions derived from TEs are far less conserved
(<1%) than non TE-derived HS site positions (~17%; Fig-
ure 3a), and the difference is highly statistically significant
(χ2 = 6.5 × 105, P = 0; Figure 3b). This finding is consistent
with the highly lineage-specific nature of TE-sequences.
Even in the human genome, where they are relatively
ancient, TEs are among the least conserved of all
sequences [1]. The lack of evolutionary conservation for
TE-derived HS sites can be taken to suggest the formal pos-
sibility these sites are not functionally relevant. However,
the analysis of gene expression data described below indi-
cates that TE-derived HS sites do in fact play a functional
role related to CD4+ T cell-specific gene regulation. Thus,
it may be the case that TE-derived HS sites provide a spe-
cific mechanism that leads to lineage-specific regulatory
phenotypes, which in turn are important for the genera-
tion of higher level phenotypic differences between spe-
cies. This interpretation is consistent with what has
previously been shown for TE-derived cis-regulatory
sequences with demonstrable roles in gene regulation, a
majority of which also show little or no evidence of evo-
lutionary conservation [10].
Gene expression
The HS sites analyzed here were cloned from CD4+ T cells.
As such, the HS site locations in the human genome
should correspond to genes that are upregulated in CD4+
T cells. This prediction was tested using Affymetrix micro-
array gene expression data from the Novartis Research
Foundation SymAtlas (GNF2) [28]. The locations of all
hg17 mapped HS sites were considered with respect to the
locations of the so-called known genes from the UCSC
genome browser. HS sites were associated with a gene if
they mapped within 1-kb of the start or end of transcrip-
tion for that gene, and Affymetrix probe identifiers were
associated with individual genes. The relative levels of
CD4+ T cell-specific gene expression were compared for
genes that have co-located HS sites and those that have no
DNaseI-hypersensitive site conservation Figure 1
DNaseI-hypersensitive site conservation. a) The per-
cent of phastCons (PC) denoted conserved positions for 
DNaseI-hypersensitive (HS) versus non DNaseI-hypersensi-
tive (nonHS) sites in the human genome. b) 2 × 2 contin-
gency table for evaluating the difference in evolutionary 
conservation between HS and nonHS sites.
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HS site. Genes associated with HS sites have significantly
higher relative CD4+ T cell expression (µ = 0.48) than non
HS site (µ = -0.21) genes (Student's t-test P = 4.5e-264;
Mann-Whitney U test, P = 8.2e-300; Figure 4a and 4b).
This is consistent with a functional role for these HS sites
in driving gene expression in CD4+ T cells. Similar results,
finding HS sites near genes with demonstrable CD4+ T
cell expression, were reported previously [17,18]. In addi-
tion, there is no real difference in the levels of CD4+ T cell
expression between TE-derived (µ = 0.48) and non TE
derived (µ = 0.47) HS sites (Student's t-test, P  = 0.82,
Mann-Whitney U test, P = 0.33; Figure 4b). This finding
underscores the functional relevance of TE-derived HS
sites: they too appear to drive CD4+ T cell specific expres-
sion.
Gene function
The GNF2 expression data was also used to guide func-
tional evaluation of genes with TE-derived HS sites. Con-
dition-specific gene expression patterns, across 73 (non-
cancerous) human tissue types and cell lines, were used to
group this set of genes with k-means clustering [29]. A
total of 25 clusters, containing genes with similar expres-
sion profiles, were resolved in this way, and five clusters
(2, 9, 15, 19 & 25) containing genes with pronounced
CD4+ T cell over-expression were chosen for functional
analysis. Genes with relatively high expression in CD4+ T
cells also tend to be over-expressed in other immune
related tissues and cells such as blood, bone marrow and
lymphoblasts (Figure 5). These coherent expression pat-
terns strongly suggest a functional role related to immune
response, and the annotation of the genes in question
bear this interpretation out.
Gene ontology (GO) annotation terms were mapped to
individual genes, and the gene members of each cluster
were evaluated for the over-representation of specific GO
(biological process) terms. GO terms found to be signifi-
cantly over-represented in two or more clusters are shown
in Table 1. When the gene expression clusters are consid-
ered from this functional annotation perspective, they
resolve into cluster- and function-specific groups. Most
prominent among these is the immune response group,
Evolutionary conservation of TE-derived versus non TE- derived HS sites Figure 3
Evolutionary conservation of TE-derived versus non 
TE-derived HS sites. a) The percent of phastCons (PC) 
denoted conserved positions for TE-derived (HSTE) and non 
TE-derived (HSnotTE) sites in the human genome. b) 2 × 2 
contingency table for evaluating the difference in evolution-
ary conservation between HSTE and HSnotTE sites.
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Relative percentages of four transposable element (TE)  classes Figure 2
Relative percentages of four transposable element 
(TE) classes. Percentages of the four classes are shown for 
the human genome as a whole (dark grey) and for HS sites 
only (light grey).
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which unites clusters 2 and 25 (as well as 19 to a lesser
extent) and contains six immune related GO terms. The
hierarchical (parent-child) relationships among these
immune related terms on the GO graph are shown in Fig-
ure 6. The most significantly over-represented GO term
covers genes specifically involved in immune response
(GO:0006955).
The functions of the individual genes that have TE-derived
HS sites as well as immune response related expression
patterns and functional annotation (GO:0006955) are
shown in Table 2. This example further emphasizes the
specific functional relevance of TE-derived HS sites. For
instance, there are a number of T cell receptor antigens,
such as CD6, CD53, CD74 and CD97, with T cell-specific
expression patterns influenced by TE insertions. These
antigens are involved in processes like cell-cell adhesion
and signalling cascades that govern the development and
proliferation of immune cells. There are also cases of
excreted cytokines (e.g. CKLF & CCLF) that are involved in
the inflammatory response by serving as potent chemoat-
tractants and stimulants for T cells. Finally, there are clin-
ically relevant genes with TE-derived HS sites, such as
CCL5, which suppresses HIV by serving as a natural ligand
for the HIV coreceptor CCR5, and BCL2, which blocks the
apoptotic death of lymphocytes and can lead to lym-
phoma when constitutively expressed.
Comparative genomics
Gene expression and function analysis point to the impor-
tance of genes with TE-derived HS sites. However, these
same TE-derived HS sites are not evolutionarily con-
served. This suggests that TE-derived HS sites may be
important in generating functional differences between
evolutionary lineages. Comparative analyses of gene
sequence and expression divergence between human and
mouse orthologs were performed to evaluate this possibil-
ity. Genes with HS sites were divided into those with TE-
derived sites and those with non TE-derived sites. These
two gene sets were mapped to 9,105 pairs of human-
mouse orthologous gene pairs described previously [30],
each member of which has GNF2 expression data. Pro-
teins encoded by genes with TE-derived HS sites have
slightly higher levels of sequence divergence (0.147 sub-
stitutions per site) compared to those encoded by genes
with non TE-derived HS sites (0.138 substitutions per
site). The difference between these average substitution
rates is only marginally significant (Student's t-test, P =
0.12, Mann-Whitney U test, P = 0.08). Genes with TE-
derived HS sites also have slightly greater evolutionary dif-
ferences in CD4+ T cell expression (1.005) than those
with non TE-derived HS sites (0.948) as measured by
comparison between human and mouse orthologs. The
difference in CD4+ T cell expression for TE-derived versus
non TE-derived HS site genes is only marginally signifi-
cant as well (Student's t-test, P = 0.08, Mann-Whitney U
test, P = 0.11). However, taken together, the differences in
evolutionary divergence at the sequence and expression
level are consistent with the idea that TE-derived HS sites
help to drive evolutionary changes between lineages. The
magnitude of this effect is fairly small though, just under
10% difference for both sequence and expression, con-
tributing to the marginal significance in each case and
indicating that many other factors are in play with respect
to the evolutionary divergence of these genes and pheno-
types.
Comparison of CD4+ T cell expression levels for different  classes of human genes Figure 4
Comparison of CD4+ T cell expression levels for dif-
ferent classes of human genes. a) Cumulative frequency 
distributions of CD4+ T cell expression for genes do not 
have any HS sites (notHS) and genes with HS sites (allHS). b) 
Comparison of average CD4+ T cell expression levels for 
without (notHS) and with (allHS) HS sites. Genes with HS 
sites were further broken down into groups of genes with 
TE-derived (HSandTE) and not TE-derived (HSnotTE) HS 
sites.
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Gene expression patterns for a cluster of coexpressed genes with TE-derived HS sites Figure 5
Gene expression patterns for a cluster of coexpressed genes with TE-derived HS sites. a) View of relative expres-
sion levels across conditions for a subset of cluster 2 genes, color coded according to over (red) and under (green) expression. 
b) Centroid view with cluster 2 expression averages.
a
bBiology Direct 2006, 1:20 http://www.biology-direct.com/content/1/1/20
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Conclusion
TEs contribute numerous HS sites to the human genome.
While TE-derived HS sites are not evolutionarily con-
served, they are functionally relevant, as demonstrated by
analyses of gene expression and functional annotations.
This distinction between conservation and function can
be taken to suggest that TEs provide a specific mechanism
for driving regulatory differences between evolutionary
lineages, and comparative genomics data bear this notion
out to some extent. Genes with TE-derived HS sites are
slightly more divergent than those non TE-derived HS
sites in terms of both sequence and CD4+ T cell expres-
sion. The results reported here point to genome-scale
effects that TEs have had in shaping the regulatory evolu-
tion of their host genomes.
Methods
Human genome sequence
The May 2004 release – National Center for Biotechnol-
ogy Information (NCBI) build 35 – of the human genome
Table 1: Overrepresented GO terms from genes with TE-derived HS sites
Clusters1 GO id2 GO level3 GO name4 Counts5 P-values6
Immune response group
2 GO:0009607 4 response to biotic stimulus 21 4.9 × 10-7
25 81 . 7  ×  1 0 -2
2 GO:0006952 5 defense response 20 1.0 × 10-6
25 81 . 6  ×  1 0 -2
2 GO:0006955 6 immune response 20 3.6 × 10-7
25 81 . 3  ×  1 0 -2
2 GO:0051707 5 response to other organism 11 1.8 × 10-4
25 53 . 3  ×  1 0 -2
2 GO:0009613 6 response to pest, pathogen or parasite 11 1.0 × 10-4
25 52 . 7  ×  1 0 -2
2 GO:0030098 9 lymphocyte differentiation 3 6.2 × 10-3
19 31 . 6  ×  1 0 -2
Regulation group
15 GO:0050789 2 regulation of biological process 40 4.4 × 10-8
25 17 7.5 × 10-3
15 GO:0050794 3 regulation of cellular process 39 2.2 × 10-8
25 17 4.1 × 10-3
15 GO:0050791 3 regulation of physiological process 38 2.2 × 10-8
25 15 1.3 × 10-6
15 GO:0051244 4 regulation of cellular physiological process 38 1.3 × 10-8
25 15 1.3 × 10-2
Metabolism group
15 GO:0050875 3 cellular physiological process 73 6.5 × 10-4
19 88 3.8 × 10-3
15 GO:0044238 4 primary metabolism 63 1.7 × 10-6
19 67 4.8 × 10-3
15 GO:0044237 4 cellular metabolism 63 9.0 × 10-6
19 71 1.3 × 10-3
9 GO:0043170 4 macromolecule metabolism 26 2.8 × 10-2
15 37 2.0 × 10-2
19 50 9.1 × 10-4
9 GO:0043283 5 biopolymer metabolism 18 2.8 × 10-2
15 30 8.0 × 10-5
19 35 5.1 × 10-4
Cell death group
2G O : 0 0 4 3 0 6 7 6 r e g u l a t i o n  o f  programmed cell death 7 7.8 × 10-3
19 73 . 7  ×  1 0 -2
2 GO:0042981 7 regulation of apoptosis 7 7.8 × 10-3
19 73 . 7  ×  1 0 -2
1Gene coexpression, based on k-means analysis, cluster identifier.
2Biological process Gene Ontology (GO) annotation term.
3Hierarchical level (descending from 1) in the biological process GO directed acyclic graph.
4Name assigned to the GO term
5Number of genes in each cluster associated with the GO term.
6P-value associated with the over-representation of the GO term in each clusterBiology Direct 2006, 1:20 http://www.biology-direct.com/content/1/1/20
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Path on the GO biological process graph leading to overrepresented functions related to immune response Figure 6
Path on the GO biological process graph leading to overrepresented functions related to immune response. 
Hierarchical levels of the directed acyclic GO graph are shown on the left. Nodes in the graph represent individual GO anno-
tation terms. Nodes are color coded according to the statistical significance level for their overrepresentation. Edges in the 
graph represent parent-child relationships between GO terms.
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Table 2: Immune response (GO:0006955) genes with TE-derived HS sites
Cluster1 Name2 Accn3 Description4 HS site5 TE6
2 CD97 NM_078481 leukocyte antigen; receptor involved in both cell adhesion and signalling processes early after leukocyte activation 12460_5 SINE/MIR/MIR
2 IGLC2 BC073786 Ig light-chain, partial Ke-Oz- polypeptide, C-term; immunoglobulin lambda constant region 2 13851_3 LTR/ERVL/LTR16A
2 IGLC1 BC070353 constant region of lambda light chains 13851_3 LTR/ERVL/LTR16A
2 MR1 CR602405 major histocompatibility complex, class I-related 1311_2 LINE/L2/L2
2 ADORA2A NM_000675 adenosine receptor subtype A2a; G-protein coupled receptor; reduces the activation status of inflammatory cells 13875_2 SINE/MIR/MIR3
2 CKLF NM_016951 chemokine-like factor (cytokine); essential role in the immune and inflammatory responses; potent chemoattractant for 
neutrophils, monocytes and lymphocytes
10591_2 SINE/Alu/AluSg
2 KLF6 NM_001008490 Kruppel-like factor 6; core promoter guanine-rich element binding protein; transcriptional activator 6794_2 SINE/MIR/MIRb
2 IL16 CR749286 interleukin 16; lymphocyte chemoattractant factor; cytokine; modulator of T cell activation; mediated by CD4 10023_2 DNA/MER1/MER117
2 ST6GAL1 NM_173216 sialyltransferase 1 (beta-galactoside alpha-2,6-sialytransferase); role in T-cell death; generation of cell-surface carbohydrate 
determinants and differentiation antigens
3308_3 SINE/MIR/MIR3
2 HLA-E NM_005516 HLA class I histocompatibility lymphocyte antigen, E alpha chain; immunoregulatory role for cytotoxic T-lymphocytes 4584_2 DNA/MER1/Charlie1
2 IL21R NM_181078 interleukin 21 receptor; type I cytokine receptor; transduces the growth promoting signal of IL21, and is important for the 
proliferation and differentiation of T cells, B cells, and natural killer (NK) cells
10408_3 SINE/MIR/MIRb
2 ITGB2 NM_000211 leukocyte cell surface adhesion glycoprotein; complement receptor C3 beta-subunit; integrin beta 2; macrophage antigen 1; 
facilitates inflammatory cell recruitment
13756_2 LINE/L1/LIME4a
2 FYB NM_001465 FYN-binding protein; adhesion and degranulation-promoting adaptor protein; adaptor helps form immunological synapse 
between T cell and antigen-presenting cell; mediates signaling from the T cell antigen receptor to integrins
3896_2 SINE/MIR/MIR3
2 IGHG1 BC024289 immunoglobulin heavy constant region gamma 1; involved in antigen binding and immune response 9667_2 LINE/L1/L1
2 PTPRC Y00062 protein tyrosine phosphatase receptor; leukocyte-common CD45 antigen; essential regulator of T- and B-cell antigen receptor 
signaling; regulator of cytokine receptor signaling; involved in hematopoiesis
1347_2 LINE/L1/L1ME
2 LCP2 NM_005565 lymphocyte cytosolic protein 2; adaptor or scaffold protein that promotes T cell development and activation as well as mast cell 
and platelet function.
4315_2 SINE/Alu/AluSx
2 CD53 NM_000560 glycoprotein leukocyte cell surface antigen; contributes to the transduction of CD2-generated signals in T cells and natural killer 
cells; role in T cell growth regulation
964_2 LINE/L2/L2
2 DOCK2 NM_004946 dedicator of cytokinesis 2; hematopoietic cell-specific CDM family protein essential for lymphocyte chemotaxis; mediates T cell 
receptor-induced activation of Rac2 and IL-2
4313_2 SINE/Alu/AluSx SINE/MIR/MIR
2 CD74 BC024272 cell surface antigen; major histocompatibility complex, class II invariant chain; involved in NF-kappaB activation and interleukin-8 
production
4254_2 DNA/MER1/Charlie8
2 MX1 NM_002462 myxovirus resistance protein 1; interferon inducible; role in host defense against viruses 13686_3 DNA/MER1/MER5A
25 CD6 U66145 glycoprotein cell surface antigen; involved in lymphocyte activation and thymocyte development; role in maturation of the 
immunological synapse
DNA/MER1/MER113
25 PLA2G4B NM_005090 phospholipase enzyme secreted by neutrophils; produces arachidonic acid used for the biosynthesis of leukotriene in 
inflammatory response
9758_2 SINE/MIR/MIRb SINE/Alu/AluY
25 BCL2 NM_000633 B-cell lymphoma protein 2; blocks the apoptotic death of some cells such as lymphocytes 12021_2 LINE/L1/HAL1
25 TRA@ BC063432 T cell antigen receptor alpha locus; involved in thymocyte developement 9169_2 9171_2 9174_4 LINE/L1/L1ME2 SINE/MIR/MIR 
LINE/L2/L2
25 CCR9 NM_031200 chemokine (C-C motif) G protein coupled receptor; regulator of thymocytes migration and maturation in normal and 
inflammation conditions; functional specialization of immune responses in different segments of the gastrointestinal tract
2827_2 LINE/L1/L1ME4a
25 TCF7 NM_003202 T cell specific transcription factor; regulates T cell development and peripheral T cell differentiation 4139_4 LINE/CR1/L3
25 CCL5 NM_002985 T cell specific chemokine (C-C motif) ligand; chemoattractant for blood monocytes, memory T helper cells and eosinophils; 
causes release of histamine from basophils and activates eosinophils;
11206_2 LINE/L1/L1MB3
25 LAT NM_001014987 linker for activation of T cells; phosphorylated following activation of the T-cell antigen receptor signal transduction pathway; 
acts as a docking site and recruits multiple adaptor proteins and downstream signaling molecules into multimolecular signaling 
complexes
10425_2 SINE/Alu/AluJb SINE/MIR/MIR
1Gene coexpression cluster from which the gene is taken.
2Official gene name symbol from the HUGO Gene nomenclature committee
3Representative mRNA Genbank accession taken from USC genome browser knownGene table.
4Brief description of the gene function
5NHGRI DNase-I hypersensitive site identifier taken from the UCSC genome browser nhgriDnaseHs table.
6Class/family/name of the transposable element (TE) sequence colocalized with the HS siteBiology Direct 2006, 1:20 http://www.biology-direct.com/content/1/1/20
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reference sequence [1] was analyzed using the UCSC
genome browser http://www.genome.ucsc.edu/[31]. The
UCSC database containing this particular release and all
associated data is referred to as hg17. The chromosome
coordinates of various attributes mapped onto the hg17
genome sequence were downloaded using the UCSC
Table Browser retrieval tool [32]. The Table Browser
retrieval tool was also used to perform a number of logical
set operations between specific tables (see below) that
allowed for the identification of co-located genomic
attributes.
Hypersensitive sites
DNaseI-hypersensitive sites (HS) from CD4+ T cells were
characterized as described [17-19]. The HS sites have been
mapped onto the hg17 sequence and their genome coor-
dinates were retrieved from the table named nhgriD-
naseHs. Only clusters of more than on HS site that map
within 500 bp of each other are mapped onto hg17.
Transposable elements
The locations and identities of all hg17 TE sequences were
characterized using the RepeatMasker program http://
www.repeatmasker.org/[26], which uses the RepBase
library [27] of repeat sequences. The genome coordinates,
along with the class, family and name designations, for
TEs were retrieved from the table named rmsk.
Gene expression and function
Human and mouse microarray gene expression data are
from the Genomics Institute of the Novartis Research
Foundation SymAtlas (GNF2) [28]. These data were
retrieved from the table named gnfAtlas2. This table stores
relative expression values for 79 different human tissues
and/or cell types (conditions). Relative expression levels
are computed as follows: Two replicate microarray exper-
iments were performed for each condition, and for each
individual probe, the expression signal intensity values
were averaged for each of the 79 pairs of experiments.
Then, for each probe, each of the 79 condition-specific
averages was normalized by the median of all values for
that probe to determine relative expression levels; these
ratios were log2 normalized prior to analysis. Affymetrix
probe identifiers are mapped to UCSC Genome Browser
known genes and these data were retrieved from the table
named  knownToGnfAtlas2. The known genes are based
mRNA data from the NCBI Reference Sequence (RefSeq)
database and GenBank along with protein data from Uni-
Prot. The chromosome coordinates for the known genes
were retrieved from the table named knownGene. After
probe-to-gene mapping, relative CD4+ T cell expression
levels were compared for different sets of human genes.
Gene expression profiles were visualized and clustered, by
k-means clustering, using the program Genesis [29]. The
Pearson correlation coefficient was used to compute pair-
wise similarities between gene expression profiles. Indi-
vidual clusters with high relative levels of CD4+ T cell
expression, as well as high expression in related tissue-
types, were chosen for further functional analysis. Clusters
(i.e. groups of genes) were evaluated with respect to over-
represented Gene Ontology (GO) [33] functional annota-
tion terms using the program GOstat [34]. The biological
process subset of the GO hierarchy was used along with
the European Bioinformatics Institute (EBI) human GO
mapping. A 2 × 2 contingency table was used to compare
the relative frequency of GO terms in the coexpression
cluster test set (observed) versus the relative frequency of
GO terms in the background set of all human GO terms
(expected) using the χ2 test, or the Fisher's exact test is the
expected value<5. The Benjamini False Discovery Rate cor-
rection for multiple testing was used to adjust the result-
ing P-values. GO annotation terms that were found to be
overrepresented in two or more different clusters were
chosen for further analysis. Individual gene functions
were explored using the NCBI Entrez Gene database http:/
/www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene. The
graphical (parent-child) relationships among GO terms
related to immune response were characterized using the
GeneInfoViz program [35]. GO term significance levels
were color coded using the program matrix2png [36].
Comparative genomics
Conserved hg17 genomic sites were characterized using
the phastCons program [23]. Alignment, using blastz [25]
and multiz [24], and comparison among 17 vertebrate
genome sequences were used to characterize conserved
sites. The genome coordinates for conserved sites were
retrieved from the table named phastConsElements17way.
Absolute differences between the relative levels of CD4+ T
cell expression were calculated for human and mouse
orthologous genes pairs described previously [30]. The
evolutionary divergence between human and mouse
orthologous proteins was measured as the number of sub-
stitutions per site using the Poisson Correction distance
[37].
Reviewers' comments
Reviewer's report 1
Wolfgang J. Miller, Laboratories of Genome Dynamics, Center
of Anatomy and Cell Biology, Medical University of Vienna,
Austria (nominated by Jerzy Jurka, Genetic Information
Research Institute, Sunnyvale, CA, USA)
Reviewer comments:
This paper provides compelling evidence that TEs did con-
tribute significantly to the evolution of novel regulatory
sections in humans and other organisms by using an ele-
gant and innovative combination between genomics with
microarray gene expression data analyses. The authorsBiology Direct 2006, 1:20 http://www.biology-direct.com/content/1/1/20
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show that up to one-fourth of the human DNAse I hyper-
sensitive sites actually stem from TEs that serve important
immune response functions in especially rapidly evolving
genes. Due to the extreme lineage-specific expansion/
silencing dynamics of TEs in different host systems
absence of evolutionary conservation of TE-derived HS
sites as reported here is not surprising. Therefore these
data are not contradicting their functional relevance as
important  cis-regulatory sections but demonstrate that
mobile DNAs in general do provide a highly attractive rep-
ertoire of structural and functional information patterns
to the host. Even after their successful inactivation via
host-directed silencing mechanisms such TE-derived cis-
regulatory sections can if proven successful be adopted by
the host genome for serving novel and innovative regula-
tory functions. It would be highly interesting to perform
comparative genomic analyses between human and chim-
panzee orthologous TE-derived HS sites in the near future.
Author's response
We would like to thank Dr. Miller for taking the time and effort
to review our manuscript. Dr. Miller suggests comparative
genomic analyses between human and chimpanzee orthologous
TE-derived HS sites. This is a good idea and may help to settle
an issue, raised by Dr. Itai Yanai (Reviewer #2 below), con-
cerning the role of TE-sequences as space holders versus the
actual contribution of TE sequences to human gene regulation.
Reviewer's report 2
Itai Yanai, Department of Molecular and Cellular Biology,
Harvard University, Cambridge, MA, USA
Reviewer Comments:
Marino-Ramirez and Jordan show in this paper that HS
sites are significantly more conserved in sequence than
non-HS sites although HS sites containing TE-derived
genes are far less conserved that HS sites lacking TE's. In
terms of gene expression, the authors show that TE-
derived genes and non-TE derived genes in HS sites are as
likely to be expressed in CD4+ T cells. Taken together,
these results lead to the conclusion that TE's are useful in
promoting gene expression evolution. This is an interest-
ing notion. I imagine that TE's insertion may be instru-
mental in modulating expression patterns by altering the
spacing among transcription binding sites as well as dis-
rupting some motifs through their insertion. Thus their
effects on gene expression may be conferred solely by their
role as space holders consequently freeing the actual TE
sequence to drift.
Indeed the authors also find that TE-derived genes evolve
slightly faster in terms of sequence and expression. How-
ever the signal is so weak that it places into question the
generality of this finding. One straightforward interpreta-
tion is that since in all likelihood most TE's that happen
to lie at HS sites do not contribute to the evolution of gene
expression, these dilute the signal to its observed weak
level.
Overall, these findings are important and should further
prompt research to attempt to distinguish those TE's
which contribute to genomic function from those that do
not.
Author's response
We would like to thank Dr. Yanai for taking the time and effort
to review our manuscript. Dr. Yanai proposes the interpretation
that "most TE's that happen to lie at HS sites [that] do not con-
tribute to the evolution of gene expression." Indeed, the evolu-
tionary divergence in CD4+ T cell expression levels for genes
containing TE-derived HS sites is only marginally greater than
that seen for genes with non TE-derived HS sites, and we point
this out in the text of the manuscript. However, the functional
relevance of TE-derived HS sites is strongly supported by their
association with genes that have relatively (significantly)
higher levels of CD4+ T cell expression (Figure 4).In addition,
genes with TE-derived HS sites have slightly higher sequence
substitution rates, on average, than genes with non TE-derived
HS sites. Taken together, these lines of evidence point to a
potential role for TE-derived HS regulatory sites in facilitating
the evolutionary divergence of human genes. To more carefully
examine this issue, we plan to investigate regulatory changes of
genes with TE-derived HS sites across species at different levels
of evolutionary divergence from the human lineage.
Dr. Yanai also raises an interesting point about the role that TE
sequences may play as 'space holders' as opposed to contributing
specific regulatory sequences. Spatial changes among promoter
elements caused by TE insertions may certainly have important
functional consequences. On the other hand, there are a
number of known, experimentally verified, cases of TE
sequences providing specific cis-regulatory binding sequences.
We are currently investigating the relative rates of evolution for
TE sequences that co-locate with regulatory regions versus those
that do not, among species that cover a range of evolutionary
divergence from human, to further investigate this possibility.
Reviewer's report 3
Mikhail S.Gelfand, Department of Bioinformatics, Institute of
Information Transfer Problems, Russian Academy of Science,
Moscow, Russia
Reviewer Comments:
The paper reports analysis of hypersensitive sites (HSs),
comparing HSs containing transposable elements (TEs)
and HSs in general. Given that HSs are likely to corre-
spond to regulatory regions and tend to be conserved, the
large fraction of TE-containing HSs is surprising. Still,Biology Direct 2006, 1:20 http://www.biology-direct.com/content/1/1/20
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even the latter are shown to be functionally relevant. This
leads to an important conclusion about the role of TEs in
the evolution of regulation.
A main problem of this study is the deficit of controls.
Basically, only two samples are analyzed, TE-HS and
nonTE-HS. For instance: 23% HSs contain TEs and 11%
HS positions are covered by TEs (page 7) – is it a lot or
not? What would be expected if there were no correlation?
(given that >50% of the human genome is TE-derived, I
suspect that, not surprisingly, HS tend to avoid HS – but
what about other classes of functional regions?)
There is no difference in gene expression between TE-HS
and nonTE-HS sites (page 9) – this is nice, but, again,
what about other classes of genes, e.g. dependent on the
degree of conservation in their upstream regions.
Section "Gene function": what genes were subject to clus-
tering in order to find over-represented GO annotations –
all HS genes? TE-HS and nonTE-HS genes separately? Fur-
ther, in the last paragraph of this section, it should be
explicitly mentioned that it describes just an example, not
an exhaustive list.
Section "Comparative genomics": missing controls are
genes without HS in the same GO categories and just
genes without HS: without it, it is difficult to appreciate
the difference between the TE-HS and nonTE-HS genes.
On the other hand, the results of this paragraph are quite
interesting: assuming that TE-HS genes recently experi-
enced a change in regulation (resulting in change in
expression), one could expect positive selection towards a
new role. It might be interesting to apply the McDonald-
Kreitman test to check this hypothesis. But again, more
controls with other classes of genes are needed.
Overall, I think that, although the obtained results are
interesting, they are somewhat preliminary. To make the
emerging picture much less shallow and enhance the
authors' main point about the contribution of TEs to the
evolution of regulation in the human genome, they
should consider, where appropriate, the following control
groups of genes: genes without HS, genes with non-con-
served (but not TE-derived) HS, non-HS genes in the same
GO categories as identified in the "Gene function" sec-
tion.
Author's response
We would like to thank Dr. Gelfand for taking the time and
effort to review our manuscript. Dr. Gelfand calls attention to
a 'deficit of controls', in several places, pointing out that only
two samples are analyzed: TE-HS versus non TE-HS containing
genes. Importantly, we have analyzed a third class of genes,
namely those that do not have any co-located HS sites charac-
terized in CD4+ T cells (non HS). This latter class of genes has
significantly lower levels of CD4+ T cell expression than either
class of HS site containing genes (TE-derived or non TE-
derived; Figure 4).This underscores the functional relevance of
both classes of HS sites characterized in CD4+ T cells, TE-
derived and non TE-derived, with respect to CD4+ T cell spe-
cific expression. Additional analysis of this third class of genes
yields slightly more ambiguous results related to the evolution-
ary divergence of human gene expression patterns. Non HS
containing genes have average levels of CD4+ T cell expression
divergence that are intermediate to those seen for TE-HS and
non TE-HS containing genes. This is in keeping with the rela-
tively weak signal seen for the differences in the average evolu-
tionary divergence of CD4+ T cell expression levels (as well as
gene sequence divergence) across different classes of genes, and
related issues were raised by the other reviewers. We have been
careful to point out this caveat in the manuscript and plan to
perform additional evolutionary comparisons (as described in
the answers to Reviewer 1 & 2 above), for instance on more
closely related species, which may help to resolve the issue of the
contribution of TE-derived HS sites to host gene regulatory
divergence.
The point raised about 11% of HS sites being covered by TEs is
also germane. This fraction is indeed less than you would expect
by chance alone given that the genome consists of ~50% TE-
derived sites. Clearly, not all TE-derived sites in the human are
functionally relevant in terms of expression and many accumu-
late simply by virtue of the selfish replicative properties of the
elements, i.e. without regard to any adaptive benefit they pro-
vide to the host genome. In fact most TE insertions into regula-
tory regions are probably deleterious, and this is consistent with
previous results that have shown exclusion of TE sequences from
proximal promoter regions. Nevertheless, the fact that a sub-
stantial fraction of human gene regulatory sites is derived from
TE-sequences underscores the potential for such elements to be
co-opted, from time-to-time, to serve some role for the host
genome in which they reside.
In the Gene function section, we have clarified that genes with
TE-derived HS sites were clustered by k-means analysis of their
tissue-specific expression patterns. Clusters with pronounced
CD4+ T cell expression levels (e.g. Figure 5)were then selected
for functional analysis with GO. In addition, as per Dr. Gel-
fand's suggestion, we explicitly point out that we describe an
example, not an exhaustive list, in the last paragraph of this sec-
tion (i.e. the data in Table 2).
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